Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Remote monitoring and digital health tools in CVD management

Nature Reviews Cardiology volume 18, pages 457–458 (2021)Cite this article

Subjects

The COVID-19 pandemic has accelerated the adoption and acceptance of remote monitoring and other digital approaches to cardiovascular disease management across the world. We argue that considerable additional effort is required to ensure appropriate multi-stakeholder involvement in the development, evaluation and best use of an ever-increasing number of digital technologies.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mueller, B. Telemedicine arrives in the U.K.: ‘10 years of change in one week’. The New York Times https://www.nytimes.com/2020/04/04/world/europe/telemedicine-uk-coronavirus.html (2020).

  2. Krittanawong, C. et al. Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management. Nat. Rev. Cardiol. 18, 75–91 (2021).

    Article  Google Scholar 

  3. McManus, R. J. et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ 372, m4858 (2021).

    Article  Google Scholar 

  4. Subedi, N., Rawstorn, J. C., Gao, L., Koorts, H. & Maddison, R. Implementation of telerehabilitation interventions for the self-management of cardiovascular disease: systematic review. JMIR Mhealth Uhealth 8, e17957 (2020).

    Article  Google Scholar 

  5. Klersy, C. et al. Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur. J. Heart Fail. 18, 195–204 (2016).

    Article  Google Scholar 

  6. Arnold, M. H. Teasing out artificial intelligence in medicine: an ethical critique of artificial intelligence and machine learning in medicine. J. Bioeth. Inq. https://doi.org/10.1007/s11673-020-10080-1 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Asteggiano, R., Cowie, M. R., Richter, D., Christodorescu, R., Guasti, L. & Ferrini, M. Survey on e-health knowledge and usage in general cardiology. Eur. Heart J. Digital Health (in the press).

  8. Frederix, I. et al. ESC e-Cardiology Working Group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur. J. Prev. Cardiol. 26, 1166–1177 (2019).

    Article  Google Scholar 

  9. Topol, E. The Topol review: preparing the healthcare workforce to deliver the digital future. Health Education England https://topol.hee.nhs.uk/ (2019).

  10. National Institute for Health and Care Excellence. Evidence standards framework for digital health technologies. https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/digital-evidence-standards-framework.pdf (2019).

Download references

Author information

Authors and Affiliations

  1. National Heart & Lung Institute, Imperial College London, London, UK

    Martin R. Cowie

  2. National Heart Centre Singapore & Duke-National University of Singapore, Singapore, Singapore

    Carolyn S. P. Lam

Authors
  1. Martin R. Cowie
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Carolyn S. P. Lam
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Martin R. Cowie.

Ethics declarations

Competing interests

M.R.C. is chair of the Digital Health Committee of the ESC. He has received research funds and consultancy fees from Abbott, Boston Scientific and Medtronic. He provides consultancy advice to AstraZeneca as Chief Physician–Scientist (heart failure). C.S.P.L. has received research support from AstraZeneca, Bayer, Boston Scientific and Roche Diagnostics; has served as consultant or on the Advisory Board, Steering Committee or Executive Committee for Actelion, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma, Janssen Research & Development, Medscape, Merck, Novartis, Novo Nordisk, Radcliffe Group, Roche Diagnostics, Sanofi, Us2.ai and WebMD Global; and serves as co-founder and non-executive director of Us2.ai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cowie, M.R., Lam, C.S.P. Remote monitoring and digital health tools in CVD management. Nat Rev Cardiol 18, 457–458 (2021). https://doi.org/10.1038/s41569-021-00548-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-021-00548-x

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing